Eye-mediated induction of specific immune tolerance to encephalitogenic antigens

CNS Neuroscience and Therapeutics

Volumn 19, Issue 7, 2013, Pages 503-510

  Farooq, Shukkur M ^a   Ashour, Hossam M ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

ACAID; Multiple sclerosis; Peripheral tolerance; T regulatory cells

Indexed keywords

ENCEPHALITOGENIC PROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ARTICLE; CD8+ T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMAGNETIC SEPARATION; IN VIVO STUDY; INFLAMMATORY CELL; INOCULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN;

ADOPTIVE TRANSFER; ANIMALS; ANTERIOR CHAMBER; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; ENCEPHALITIS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNOMAGNETIC SEPARATION; INJECTIONS; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; MYELIN BASIC PROTEIN; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OCULAR PHYSIOLOGICAL PHENOMENA; SPLEEN;

EID: 84879022405     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12087     Document Type: Article

References (55)

1. Taylor AW. Ocular immune privilege. Eye (Lond) 2009;23:1885-1889.
2. Medawar PB. A second study of the behaviour and fate of skin homografts in rabbits: a report to the war wounds committee of the medical research council. J Anat 1945;79:157-176, 154.
3. Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948;29:58-69.
4. Forrester JV, Xu H, Lambe T, Cornall R. Immune privilege or privileged immunity? Mucosal Immunol 2008;1:372-381.
5. Ashour HM, Niederkorn JY. Gammadelta t cells promote anterior chamber-associated immune deviation and immune privilege through their production of il-10. J Immunol 2006;177:8331-8337.
6. Ashour HM, Niederkorn JY. Peripheral tolerance via the anterior chamber of the eye: role of b cells in mhc class i and ii antigen presentation. J Immunol 2006;176:5950-5957.
7. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003;3:879-889.
8. Niederkorn JY. Regulatory t cells and the eye. Chem Immunol Allergy 2007;92:131-139.
9. Niederkorn JY. The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy 2007;92:27-35.
10. Wilbanks GA, Streilein JW. Characterization of suppressor cells in anterior chamber-associated immune deviation (acaid) induced by soluble antigen. Evidence of two functionally and phenotypically distinct t-suppressor cell populations. Immunology 1990;71:383-389.
11. Kuerten S, Angelov DN. Comparing the cns morphology and immunobiology of different eae models in c57bl/6 mice - a step towards understanding the complexity of multiple sclerosis. Ann Anat 2008;190:1-15.
12. Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A. The myelin-associated oligodendrocytic basic protein (mobp) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev 2010;9:233-236.
13. Li J, Zhao X, Skoff R, Shaw MK, Tse HY. Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encephalomyelitis in two h-2b-restricted mouse strains. J Neuroimmunol 2011;234:109-114.
14. Guo X, Harada C, Namekata K, et al. Delayed onset of experimental autoimmune encephalomyelitis in olig1 deficient mice. PLoS ONE 2010;5:e13083.
15. Kuerten S, Schickel A, Kerkloh C, et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific t cell response. Acta Neuropathol 2012;124:861-873.
16. Yin LL, Lin LL, Zhang L, Li L. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses. Neuropharmacology 2012;63:851-862.
17. Forghani R, Wojtkiewicz GR, Zhang Y, et al. Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. Radiology 2012;263:451-460.
18. Kaushansky N, Zilkha-Falb R, Hemo R, et al. Pathogenic t cells in mobp-induced murine eae are predominantly focused to recognition of mobp21f and mobp27p epitopic residues. Eur J Immunol 2007;37:3281-3292.
19. de Rosbo NK, Kaye JF, Eisenstein M, et al. The myelin-associated oligodendrocytic basic protein region mobp15-36 encompasses the immunodominant major encephalitogenic epitope(s) for sjl/j mice and predicted epitope(s) for multiple sclerosis-associated hla-drb1*1501. J Immunol 2004;173:1426-1435.
20. Kaushansky N, Eisenstein M, Oved JH, Ben-Nun A. Activation and control of pathogenic t cells in osp/claudin-11-induced eae in sjl/j mice are dominated by their focused recognition of a single epitopic residue (osp58 m). Int Immunol 2008;20:1439-1449.
21. Kaushansky N, Hemo R, Eisenstein M, Ben-Nun A. Osp/claudin-11-induced eae in mice is mediated by pathogenic t cells primarily governed by osp192y residue of major encephalitogenic region osp179-207. Eur J Immunol 2007;37:2018-2031.
22. Lu L, Cantor H. Generation and regulation of cd8(+) regulatory t cells. Cell Mol Immunol 2008;5:401-406.
23. Bhowmick S, Clark RB, Brocke S, Cone RE. Antigen-specific splenic cd4+ and cd8+ regulatory t cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase. Int Immunol 2011;23:119-128.
24. Faunce DE, Terajewicz A, Stein-Streilein J. Cutting edge: in vitro-generated tolerogenic apc induce cd8+ t regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol 2004;172:1991-1995.
25. Ashour HM, Niederkorn JY. Expansion of b cells is necessary for the induction of t-cell tolerance elicited through the anterior chamber of the eye. Int Arch Allergy Immunol 2007;144:343-346.
26. Konya C, Goronzy JJ, Weyand CM. Treating autoimmune disease by targeting cd8(+) t suppressor cells. Expert Opin Biol Ther 2009;9:951-965.
27. Cone RE, Chattopadhyay S, O'Rourke J. Control of delayed-type hypersensitivity by ocular- induced cd8+ regulatory t cells. Chem Immunol Allergy 2008;94:138-149.
28. Niederkorn JY. Mechanisms of immune privilege in the eye and hair follicle. J Invest Dermatol 2003;8:168-172.
29. Li X, Shen S, Urso D, et al. Phenotypic and immunoregulatory characteristics of monocytic iris cells. Immunology 2006;117:566-575.
30. Faunce DE, Sonoda KH, Stein-Streilein J. Mip-2 recruits nkt cells to the spleen during tolerance induction. J Immunol 2001;166:313-321.
31. Keino H, Takeuchi M, Kezuka T, et al. Induction of eye-derived tolerance does not depend on naturally occurring cd4+ cd25+ t regulatory cells. Invest Ophthalmol Vis Sci 2006;47:1047-1055.
32. Lin HH, Faunce DE, Stacey M, et al. The macrophage f4/80 receptor is required for the induction of antigen-specific efferent regulatory t cells in peripheral tolerance. J Exp Med 2005;201:1615-1625.
33. Sonoda KH, Stein-Streilein J. Cd1d on antigen-transporting apc and splenic marginal zone b cells promotes nkt cell-dependent tolerance. Eur J Immunol 2002;32:848-857.
34. Skelsey ME, Mayhew E, Niederkorn JY. Cd25+, interleukin-10-producing cd4+ t cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003;110:18-29.
35. Katagiri K, Zhang-Hoover J, Mo JS, Stein-Streilein J, Streilein JW. Using tolerance induced via the anterior chamber of the eye to inhibit th2-dependent pulmonary pathology. J Immunol 2002;169:84-89.
36. Streilein JW, Takeuchi M, Taylor AW. Immune privilege, t-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol 1997;52:138-143.
37. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated t cells expressing il-2 receptor alpha-chains (cd25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
38. Stern ME, Schaumburg CS, Dana R, Calonge M, Niederkorn JY, Pflugfelder SC. Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol 2010;3:425-442.
39. Longhi MS, Hussain MJ, Mitry RR, et al. Functional study of cd4+ cd25+ regulatory t cells in health and autoimmune hepatitis. J Immunol 2006;176:4484-4491.
40. Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of t cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010;52:999-1007.
41. Wang YM, Zhang GY, Hu M, et al. Cd8+ regulatory t cells induced by t cell vaccination protect against autoimmune nephritis. J Am Soc Nephrol 2012;23:1058-1067.
42. Allenbach Y, Solly S, Gregoire S, et al. Role of regulatory t cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 2009;174:989-998.
43. Berthelot L, Laplaud DA, Pettre S, et al. Blood cd8+ t cell responses against myelin determinants in multiple sclerosis and healthy individuals. Eur J Immunol 2008;38:1889-1899.
44. Correale J, Villa A. Isolation and characterization of cd8+ regulatory t cells in multiple sclerosis. J Neuroimmunol 2008;195:121-134.
45. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. Cd4(+)cd25(+) regulatory t cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004;50:2775-2785.
46. Jung S, Park YK, Lee H, Shin JH, Lee GR, Park SH. Tgf-beta-treated antigen presenting cells suppress collagen- induced arthritis through the promotion of th2 responses. Exp Mol Med 2010;42:187-194.
47. Davila E, Kang YM, Park YW, et al. Cell-based immunotherapy with suppressor cd8+ t cells in rheumatoid arthritis. J Immunol 2005;174:7292-7301.
48. Singh RP, La Cava A, Wong M, Ebling F, Hahn BH. Cd8+ t cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on foxp3 expression. J Immunol 2007;178:7649-7657.
49. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC. Tcr stimulation with modified anti-cd3 mab expands cd8+ t cell population and induces cd8+ cd25+ tregs. J Clin Invest 2005;115:2904-2913.
50. Cunnusamy K, Chen PW, Niederkorn JY. Il-17a-dependent cd4+ cd25+ regulatory t cells promote immune privilege of corneal allografts. J Immunol 2011;186:6737-6745.
51. Menager-Marcq I, Pomie C, Romagnoli P, van Meerwijk JP. Cd8+ cd28- regulatory t lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006;131:1775-1785.
52. Elliott EA, McFarland HI, Nye SH, et al. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 1996;98:1602-1612.
53. Zhong MC. Kerlero de Rosbo N, Ben-Nun A. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. J Clin Invest 2002;110:81-90.
54. Leadbetter EA, Bourque CR, Devaux B, et al. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide. J Immunol 1998;161:504-512.
55. Smith CE, Miller SD. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing eae associated with multiple pathogenic autoreactivities. J Autoimmun 2006;27:218-231.